In academic publishing, a preprint is a version of a scholarly or scientific paper that precedes formal peer review and publication in a peer-reviewed scholarly or scientific journal. The preprint may be available, often as a non-typeset version available free, before or after a paper is published in a journal.
MEDLINE is a bibliographic database of life sciences and biomedical information. It includes bibliographic information for articles from academic journals covering medicine, nursing, pharmacy, dentistry, veterinary medicine, and health care. MEDLINE also covers much of the literature in biology and biochemistry, as well as fields such as molecular evolution.
Open access (OA) is a set of principles and a range of practices through which research outputs are distributed online, free of access charges or other barriers. With open access strictly defined, or libre open access, barriers to copying or reuse are also reduced or removed by applying an open license for copyright.
Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, plant biology, genomics, and quantitative biology.
PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine (NLM) at the National Institutes of Health maintain the database as part of the Entrez system of information retrieval.
The BMJ is a weekly peer-reviewed medical journal, published by BMJ Group, which in turn is wholly-owned by the British Medical Association (BMA). The BMJ has editorial freedom from the BMA. It is one of the world's oldest general medical journals. Previously called the British Medical Journal, the title was officially shortened to BMJ in 1988, and then changed to The BMJ in 2014. The journal is published by BMJ Publishing Group Ltd, a subsidiary of the British Medical Association (BMA). The current editor-in-chief of The BMJ is Kamran Abbasi, who was appointed in January 2022.
PubMed Central (PMC) is a free digital repository that archives open access full-text scholarly articles that have been published in biomedical and life sciences journals. As one of the major research databases developed by the National Center for Biotechnology Information (NCBI), PubMed Central is more than a document repository. Submissions to PMC are indexed and formatted for enhanced metadata, medical ontology, and unique identifiers which enrich the XML structured data for each article. Content within PMC can be linked to other NCBI databases and accessed via Entrez search and retrieval systems, further enhancing the public's ability to discover, read and build upon its biomedical knowledge.
Open peer review is the various possible modifications of the traditional scholarly peer review process. The three most common modifications to which the term is applied are:
- Open identities: Authors and reviewers are aware of each other's identity.
- Open reports: Review reports are published alongside the relevant article.
- Open participation: The wider community are able to contribute to the review process.
An overlay journal or overlay ejournal is a type of open access academic journal, almost always an online electronic journal (ejournal), that does not produce its own content, but selects from texts that are already freely available online. While many overlay journals derive their content from preprint servers, others, such as the Lund Medical Faculty Monthly, contain mainly papers published by commercial publishers, but with links to self-archived preprint or postprints when possible.
PLOS Currents was a publishing platform run by the Public Library of Science from 2009 to 2018 as an experiment.
German National Library of Medicine, abbreviated ZB MED – Information Centre for Life Sciences in Cologne, together with the Bonn site, is the central specialist library for medicine, public health, nutrition, environmental and agricultural sciences in Germany. The focus is on collection development, full text supply and projects in the field of information sciences. ZB MED provides science, research, students and other interested parties with specialist literature and information. It is financed by the Federal Government and Federal State of North Rhine-Westphalia.
bioRxiv is an open access preprint repository for the biological sciences co-founded by John Inglis and Richard Sever in November 2013. It is hosted by the Cold Spring Harbor Laboratory (CSHL).
In India, Open Access movement started in May 2004, when two workshops were organized by the M S Swaminathan Research Foundation, Chennai. In 2006, the National Knowledge Commission in its recommendations proposed that "access to knowledge is the most fundamental way of increasing the opportunities and reach of individuals and groups". In 2009, the Council of Scientific & Industrial Research (CSIR) began requiring that its grantees provide open access to funded research. In 2011, the Open Access India forum formulated a draft policy on Open Access for India. Shodhganga, a digital repository for theses, was established in 2011 with the aim of promoting and preserving academic research. The University Grants Commission (UGC) made it mandatory for scholars to deposit their theses in Shodhganga, as per the Minimum Standards and Procedure for Award of M. Phil./Ph.D. Degrees Regulations, 2016.Currently, the Directory of Open Access Journals lists 326 open access journals published in India, of which 233 have no fees.
ChemRxiv is an open access preprint archive for chemistry. It is operated by the American Chemical Society, Royal Society of Chemistry and German Chemical Society. The new preprint server was announced already in 2016, but was only opened online in 2017. Initially, editors of ACS journals were skeptical and only 80% of the editors allowed submissions to be uploaded to the preprint server in 2017. In 2019 the Chinese Chemical Society and the Chemical Society of Japan joined as co-owners of the preprint server.
The Office of Portfolio Analysis was established in the Division of Program Coordination, Planning, and Strategic Initiatives in 2011 to assist NIH Institutes and Centers with scientific portfolio analysis. Per the Federal Register, the Office of Portfolio Analysis serves the following goals:
- Prepare and analyze data on NIH sponsored biomedical research to inform trans-NIH planning and coordination;
- Serve as a resource for portfolio management at the programmatic level;
- Employ databases, analytic tools, methodologies and other resources to conduct assessments in support of portfolio analyses and priority setting in scientific areas of interest across NIH;
- Research and develop new analytic tools, support systems, and specifications for new resources in coordination with other NIH organizations to enhance the management of the NIH's scientific portfolio; and
- Provide, in coordination with other NIH organizations, training on portfolio analysis tools, procedures, and methodology.
The Randomised Evaluation of COVID-19 Therapy is a large-enrollment clinical trial of possible treatments for people in the United Kingdom admitted to hospital with severe COVID-19 infection. The trial was later expanded to Indonesia, Nepal and Vietnam. The trial has tested ten interventions on adults: eight repurposed drugs, one newly developed drug and convalescent plasma.
Harlan M. Krumholz, MD, SM is an American cardiologist, leading research scientist, and the Harold H. Hines, Jr. Professor of Medicine at Yale School of Medicine, where he has been on faculty since 1992. A pioneer in the development of the field of outcomes research, his groundbreaking contributions to science have directly led to improvements in healthcare outcomes for patients and populations. He is an international expert in the science to evaluate and improve the quality and efficiency of care, reduce disparities, improve integrity in medical research, promote better health policies and regulations, and promote patient-centeredness in research and clinical care. He is the founder and director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation.
Rapid Reviews: Infectious Diseases, also known as RR\ID and formerly known as Rapid Reviews: COVID-19, or RR:C19, is an open access interdisciplinary medical journal published by the MIT Press. It publishes peer reviews and editorials of timely, publicly-posted preprints relevant to all aspects of the COVID-19 pandemic. The journal was established in June 2020 with Stefano Bertozzi as editor-in-chief.
